Genzyme Recalls Clolar Injection Due to Missing Package Insert
Genzyme Corporation is recalling Clolar (clofarabine) injection vials because the package insert is incorrect or missing.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The FDA classified this as a Class III recall, which the rubric defines as typically resulting in a score of 1 or 2 because it is unlikely to cause adverse health consequences. The issue is a documentation/packaging defect (missing insert) rather than a direct safety hazard.
Plain-English summary
Genzyme Corporation is recalling 9,343 single-dose vials of Clolar (clofarabine) 20 mg/20 mL (1 mg/mL) Injection, for intravenous use. The recall was initiated because the product has an incorrect or missing package insert.
The affected product is manufactured by Teva Pharmachemie for Genzyme Corporation and is distributed nationwide. The recall includes vials from three specific lots: K5006Y01 (expiration 08/31/18), K5006Y03 (expiration 08/31/18), and K6001Y01 (expiration 03/31/19).
Healthcare providers and patients should check their inventory for these specific lot numbers and expiration dates. The FDA has classified this recall as Class III, indicating that use of or exposure to the violative product is not likely to cause adverse health consequences.
The recalled product
- Product
- Clolar (clofarabine) 20 mg/20 mL (1 mg/mL) Injection, for intravenous use, Rx Only, Mfd. by: Teva Pharmachemie Swensweg 5 Haarlem, The Netherlands Mfd. for: Genzyme Corporation, Cambridge, MA 02142, NDC 0024-5860-01.
- Manufacturer
- Genzyme Corporation
- Category
- Drug — Antineoplastic
- Hazard
- Affected units
- 9,343
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot #: K5006Y01
- Exp. 08/31/18 Lot #: K5006Y03
- Exp. 08/31/18 Lot #: K6001Y01
- Exp. 03/31/19
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Genzyme Corporation
See all →- LowGenzyme Recalls Lumizyme Vials Due to Incorrect or Missing Lot and Expiration Dates
FDA (Drugs) · 2016-04-06
- SevereGenzyme Recalls Thyrogen Injection Vials Due to Glass Particulate Matter
FDA (Drugs) · 2016-03-09
- SevereGenzyme Recalls Thyrogen Due to Glass Particles Found in Product
FDA (Drugs) · 2016-03-09
- HighGenzyme Recalls Seprafilm Adhesion Barrier Packs Due to Packaging Defect
FDA (Devices) · 2012-06-27
- HighGenzyme Recalls Seprafilm Adhesion Barrier Due to Packaging Sterility Risk
FDA (Devices) · 2012-06-27
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02